Sector Update: Healthcare

By
A A A

Healthcare shares are fairly flat in pre-market. Among the major movers, shares in IntelliPharmaCeutics International Inc. ( IPCI ) have spiked about 80% pre-market after the maker of controlled and targeted-release drugs won final FDA approval of its 15 and 30 milligram formulations of dexmethylphenidate hydrochloride extended-release capsules.

The stock recently changed hands at $3.15 after hitting an earlier high of $3.72, its best level since August 2011.

And, Medtronic ( MDT ) is down about 1% as it reports Q2 revenue of $4.19 bln, vs. the analyst consensus of $4.17 bln on Capital IQ. Adjusted EPS was $0.91, vs. expectations of $0.90 per share.


For FY 2014, the company continues to expect full year revenue growth in the range of 3% to 4% on a constant currency basis and EPS in the range of $3.80 to $3.85. The Street view is $3.82 per share.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: IPCI , MDT

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

33,974,386
  • $17.98 ▲ 0.28%
20,763,901
  • $91.29 ▲ 2.06%
19,110,793
  • $7.26 ▼ 1.22%
18,528,869
    $8.33 unch
18,014,920
  • $4.19 ▼ 1.18%
16,448,919
  • $25.83 ▼ 0.19%
14,748,190
  • $7.60 ▼ 1.43%
14,144,383
  • $112.01 ▼ 0.47%
As of 12/24/2014, 02:12 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com